Pharmaceutical Contract Manufacturing and Research Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Global Pharmaceutical Contract Manufacturing and Research Services Market is Segmented by Manufacturing Services (API/Bulk Drugs, Advanced Drug Delivery Formulations Packaging, Packaging and Finished Dose Formulations(Solid Formulations, Liquid Formulations, and Semi-Solid Formulations), Research Services (Oncology, Vaccines, Cardiology, Neuroscience, and Other Research Services) and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The report offers the value (USD million) for the above segments.

Market Snapshot

Pharmaceutical Contract Manufacturing And Research Services Market Size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Pharmaceutical Contract Manufacturing and Research Services Market is expected to register a CAGR of nearly 7 % over the forecast period, 2022-2027.

The COVID-19 pandemic has significantly impacted the market. The pandemic affected the pharmaceutical industry's supply chain and distribution channels, negatively impacting the market growth. However, the pandemic also boosted the demand for contract manufacturing and research services. For instance, in December 2020, a CDMO, Recipharm signed an agreement with Moderna pharmaceutical company. As per the agreement, Recipharm supported the fill-finish part of the Moderna COVID-19 vaccine for supply to countries outside the United States.

Additionally, in January 2021, ICON PLC collaborated with Pfizer Inc. and BioNTech to provide clinical trial services to develop Pfizer and BioNTech's investigational COVID-19 vaccine program. As a part of this program, ICON worked in more than 153 sites in Europe, South Africa, the United States, and Latin America to recruit 44,000 participants for the clinical trial studies. It also provided site training, document management, and operational support for patient informed consent form review. Thus, the COVID-19 pandemic positively impacted market growth.

The major factors attributing to the market growth are growing demand to develop pharmaceutical drugs, low manufacturing costs, improving economic conditions of developing countries, and rising use of biologics.

Growing demand to develop pharmaceutical drugs is driving the demand for pharmaceutical contract manufacturing and research services market. Several market players are engaged in the implementation of strategic initiatives. For instance, in October 2020, PPD Inc. reported its expansion by opening a new multipurpose clinical research laboratory in Suzhou, China, to offer bioanalytical, biomarker, and vaccine services for clinical trials across all phases of pharmaceutical development, thereby contributing to the market growth. Also, in October 2021, CTI Clinical Trial & Consulting Services (CTI), a global contract research organization (CRO) specializing in personalized curative therapies and complex clinical programs, signed a formal, worldwide partnership agreement with BioAgilytix, a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development.

Additionally, as per the September 2020 update by the Pharmaceutical Research and Manufacturers of America (PhRMA), the PhRMA members had invested nearly USD 83 billion in R&D activities in 2019. Furthermore, as per the same source, more than 260 vaccines are in the pipeline by biopharmaceutical companies for various diseases, including COVID-19, as per PhRMA, 2020. Moreover, as per the Organization for Economic Co-Operation and Development (OECD), pharmaceutical spending as a percentage of gross domestic product (GDP) in 2020 was 6.9% in the Netherlands, 7.2 % in Norway, 11.1 % in Iceland, 12.4% in Finland and 19.3% in South Korea.

However, regulatory issues about drug approval and limited outsourcing opted by pharmaceutical companies impede market growth.

Scope of the Report

As per the scope of the report, pharmaceutical contract manufacturing and research services such as assay development or drug discovery are offered by contract manufacturing and contract research organizations on a contractual basis. The market is segmented by Manufacturing Services, Research Services, and Geography. The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.

By Manufacturing Services
API/Bulk Drugs
Advanced Drug Delivery Formulations Packaging
Finished Dose Formulations
Solid Formulations
Liquid Formulations
Semi-Solid Formulations
By Research Services
Inflammation and Immunology
Other Research Services
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oncology Segment is Expected to Hold a Major Market Share in the Pharmaceutical Contract Manufacturing and Research Services Market

The oncology segment is expected to hold a major share in the market. The oncology segment is expected to show growth owing to the factors such as the increasing prevalence of cancer and a growing number of initiatives undertaken by the market players.

For instance, according to the World Health Organization (WHO), cancer accounted for approximately 10 million deaths in 2020, nearly one in six. Also, per the GLOBOCAN 2020, the estimated number of new cancer cases worldwide is predicted to reach 30.2 million by 2040. Such high numbers indicate that the estimated rising prevalence of cancer contributes to the increasing need for pharmaceutical contract research services, proliferating market growth.

In addition, several market players are primarily engaged in implementing strategic initiatives, thereby fueling the market’s growth. For instance, in February 2021, Parexel, one of the leading providers of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, and NeoGenomics, Inc., one of the leading providers of cancer-focused genetic testing services and global oncology contract research services, entered a strategic partnership to advance the application of precision medicine in oncology clinical trials by applying real-world genomics data to accelerate patient matching and optimize trial design, site selection, clinical development, and translational research.

Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.

Pharmaceutical Contract Manufacturing And Research Services Market Share

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

Within North America, the United States has held the major share of the market. It can be attributed to the growing burden of chronic diseases and key regional players, especially in the United States.

For instance, as per the 2022 American Cancer Society, an estimated 1.9 million new cancer cases will be diagnosed and 609,360 cancer deaths in the United States in 2022. Such a high burden of cancer leads to increased production of drugs for cancer treatment, for which the drug manufacturing companies are entering into partnerships with pharmaceutical contract manufacturing and research services companies that are augmenting the market growth.

In addition, in May 2020, the United States Department of Commerce’s National Institute of Standards and Technology (NIST) funded around USD 8.9 million to the highly impacted biopharmaceutical manufacturing projects in response to the outbreak. This factor further contributes to the growth of pharmaceutical contract manufacturing and research services.

Moreover, several market players implement strategic initiatives, thereby contributing to market growth. For instance, in January 2022, Recro Pharma Inc., contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, reported being awarded a new formulation development and cGMP manufacturing contract from a key department of the United States government.

Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned developments.

Pharmaceutical Contract Manufacturing And Research Services Market Growth

Competitive Landscape

The pharmaceutical contract manufacturing and research services market is competitive with several global and international players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Key players in the market are Thermo Fisher Scientific (PPD, Inc. ), AbbVie, Baxter BioPharma, Dalton Pharma Services, and Boehringer Ingelheim Biopharmaceuticals GmbH.

Recent Developments

In March 2022, Silo Pharma, Inc., a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, entered an agreement with Frontage Laboratories, a CRO (contract research organization), providing integrated, science-driven product development services throughout the drug discovery and development process that enable life science companies to achieve their drug development goals.

In March 2022, Piramal Pharma Limited's Pharma Solutions (PPS) business, one of the leading Contract Research, Development, and Manufacturing Organizations (CDMO), reported that the company had made a multi-million dollar investment to create a world-class high-throughput screening facility that will augment the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India. This new expansion will significantly add to the primary and secondary screening capabilities of compounds prepared at the Ahmedabad site.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Demand To Develop Pharmaceutical Drugs

      2. 4.2.2 Low Manufacturing Cost And Improving Economic Condition of Developing Countries

      3. 4.2.3 Rising Use of Biologics

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory Issues Pertaining to the Drug Approval

      2. 4.3.2 Limited Outsourcing Opted by Pharmaceutical Companies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value- USD million)

    1. 5.1 By Manufacturing Services

      1. 5.1.1 API/Bulk Drugs

      2. 5.1.2 Advanced Drug Delivery Formulations Packaging

      3. 5.1.3 Packaging

      4. 5.1.4 Finished Dose Formulations

        1. Solid Formulations

        2. Liquid Formulations

        3. Semi-Solid Formulations

    2. 5.2 By Research Services

      1. 5.2.1 Oncology

      2. 5.2.2 Vaccines

      3. 5.2.3 Inflammation and Immunology

      4. 5.2.4 Cardiology

      5. 5.2.5 Neuroscience

      6. 5.2.6 Other Research Services

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific (PPD, Inc. )

      2. 6.1.2 AbbVie

      3. 6.1.3 Baxter BioPharma

      4. 6.1.4 Dalton Pharma Services

      5. 6.1.5 Boehringer Ingelheim Biopharmaceuticals GmbH

      6. 6.1.6 Lonza AG

      7. 6.1.7 Aurigene Pharmaceutical Services Ltd.

      8. 6.1.8 Sterling Pharma Solutions

      9. 6.1.9 Symbiosis Pharmaceutical Services

      10. 6.1.10 Piramal Pharma Solutions

      11. 6.1.11 Evonik Industries AG

      12. 6.1.12 Labcorp Drug Development

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Pharmaceutical Contract Manufacturing and Research Services market is studied from 2019 - 2027.

The Global Pharmaceutical Contract Manufacturing and Research Services is growing at a CAGR of 7% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Thermo Fisher Scientific (PPD, Inc. ), AbbVie, Baxter BioPharma, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmbH are the major companies operating in Global Pharmaceutical Contract Manufacturing and Research Services.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!